Skip to Main Content

LOS ANGELES — This city is now home to its very first biotech venture firm: Dr. Beth Seidenberg, a general partner at Kleiner Perkins, will now be heading up a $320 million fund called Westlake Village BioPartners dedicated exclusively to the life sciences — and, potentially, helping build up the LA area as a new biotech hub.

Seidenberg, former chief medical officer of Amgen, is bringing on board Sean Harper — who by January will end his tenure as R&D head at the Los Angeles-area biotech. Some of the better-known companies in Seidenberg’s portfolio include ovarian cancer therapeutics company Tesaro, allogeneic T cell company Atara Biotherapeutics, and epigenetics player Epizyme.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!